immunotherapy

Home/Tag: immunotherapy

Gene Immunotherapy Protects Against MS in Mice

A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an autoimmune disease in which T cells destroy the myelin sheath--the material that surrounds and protects nerve cells in the brain and spinal cord. The

The Vital Role of Emerging Gene Transfer Methods in T-cell Cancer Therapy

Cancer is one of the leading causes of death worldwide, with new cases expected to rise by 70 percent over the next two decades, making the search for an effective treatment more important now than ever before. Great strides have been made in recent years in the form of cancer immunotherapies. Inspired by discoveries about

September 1st, 2017|Categories: Cancer, Disease Specific|Tags: , , |

Novel ‘Barcode’ tracking T-cells in Immunotherapy Patients identifies likely cancer

Wed, 03/01/2017 - 10:17am by Fred Hutchinson Cancer Research Center A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer. The findings will be published February

New topical immunotherapy effective against early skin cancer

Combination of two drugs reduces precancerous skin lesions By Julia Evangelou Strait November 21, 2016 Washington University dermatologist Lynn Cornelius, MD, (left) conducts a skin exam with patient Robert Manchester. Manchester is a participant in a clinical trial testing the effectiveness of a new topical immunotherapy against precancerous skin lesions called actinic keratosis, often found

New immunotherapy for leukemia shows promise in small clinical trial

'Training' immune cells boosts effectiveness in patients with AML By Julie Evangelou Strait September 21, 2016 A new type of immunotherapy shows promise against cases of acute myeloid leukemia (AML) that recur after treatment or that never respond to therapy in the first place. A small clinical trial at Washington University School of Medicine in St. Louis

Napster Co-Founder Funds Immunotherapy Research Project

Wed, 04/13/2016 - 10:00am Ryan Bushey, Digital Editor, R&D Parker (left) made a generous donation to cancer research. (Credit: The Parker Institute)Sean Parker, the entrepreneur behind music-sharing service Napster, is providing a $250 million grant to support a consortium aimed at development of immunotherapy research.This venture, a non-profit named the Parker Institute for Cancer Immunotherapy, will

Laser surgery opens blood-brain barrier to chemotherapy

Technology may improve treatment for deadly brain cancer by Jim Goodwin•February 24, 2016 ROBERT BOSTON PHOTO Washington University neurosurgeon Eric C. Leuthardt, MD, and others have discovered another benefit of laser surgery for patients with glioblastomas, one of the most difficult cancers to treat. In addition to killing the tumors with heat, the technology bypasses

Magnetic Nanoparticles Could Be Key To Effective Immunotherapy

New method moves promising strategy closer to clinical use Release Date: July 15, 2015 FAST FACTS: Immunotherapy is based on the idea of training the body’s own immune cells to better combat cancer, infections and other diseases. A major challenge to its success has been the inability to produce enough trained immune cells to have

Recruiting the entire immune system to attack cancer

Stimulating both major branches of the immune system halts tumor growth more effectively. Anne Trafton | MIT News Office April 13, 2015 The human immune system is poised to spring into action at the first sign of a foreign invader, but it often fails to eliminate tumors that arise from the body’s own cells. Cancer

Immunotherapy: New Hope for Patients with Advanced Lung Cancer

First steps toward precision medicine for a deadly disease March 12, 2015 In the late 1800s, a New York surgeon named William Coley noticed that some patients with cancer seemed to fare better if they developed an infection after undergoing surgery. Suspecting that the immune system played a role in this mysterious response, he tried